Europe — EMA
Octreotid Hameln (Octreotide)
Octreotide, the active ingredient in Octreotid Hameln, is a peptide synthetic analogue of somatostatin presented as a strength/form for injection use.
Request sourcing
What is Octreotide?
Octreotide, the active ingredient in Octreotid Hameln, is a peptide synthetic analogue of somatostatin presented as a strength/form for injection use. It regulates hormone secretion and is employed in the management of specific endocrine disorders in adults. GNH USA supplies Octreotid Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
GNH USA supplies Octreotid Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
What is Octreotide used for?
Octreotide is a somatostatin analogue that modulates neuroendocrine activity across several clinical pathways.
- Acromegaly: reduces growth hormone and IGF‑1 levels, helping control disease activity. - Carcinoid syndrome: decreases flushing and diarrhoea by inhibiting serotonin release. - VIPoma and PH‑ V .... .... . - … … . - ...
What are the side effects of Octreotide?
...
What precautions apply to Octreotide?
...
What does Octreotide interact with?
...
